Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Recombinant humanised monoclonal antibody to human Nogo-A protein of the IgG1/kappa class

EU orphan designation number: EU/3/10/797
Active ingredient: Recombinant humanised monoclonal antibody to human Nogo-A protein of the IgG1/kappa class
Indication: Treatment of amyotrophic lateral sclerosis
Sponsor: Glaxo Group Ltd
980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
06/10/2010 Orphan designation EMA/OD/060/10 (2010)6942 of 01/10/2010
04/02/2014 Change of address of sponsor
20/07/2015 Removal of orphan designation from Community Register